c-Met has recently gained significant attention due to it is being associated with the cancer stem cell population6 and also acting as a key component of resistance mechanism against epidermal growth factor receptor (EGFR) inhibition by novel therapeutics such as cetuximab7. This evidence concerns the gene MET and cancer.